IL152958A0 - Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls - Google Patents

Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls

Info

Publication number
IL152958A0
IL152958A0 IL15295801A IL15295801A IL152958A0 IL 152958 A0 IL152958 A0 IL 152958A0 IL 15295801 A IL15295801 A IL 15295801A IL 15295801 A IL15295801 A IL 15295801A IL 152958 A0 IL152958 A0 IL 152958A0
Authority
IL
Israel
Prior art keywords
high levels
chlorophylls
xanthophylls
purification
contain high
Prior art date
Application number
IL15295801A
Other languages
English (en)
Original Assignee
Prodemex Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodemex Sa De Cv filed Critical Prodemex Sa De Cv
Publication of IL152958A0 publication Critical patent/IL152958A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/24—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by six-membered non-aromatic rings, e.g. beta-carotene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15295801A 2000-06-09 2001-06-07 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls IL152958A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/590,611 US6329557B1 (en) 2000-06-09 2000-06-09 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
PCT/IB2001/001217 WO2001094279A2 (en) 2000-06-09 2001-06-07 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls

Publications (1)

Publication Number Publication Date
IL152958A0 true IL152958A0 (en) 2003-06-24

Family

ID=24362926

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15295801A IL152958A0 (en) 2000-06-09 2001-06-07 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
IL152958A IL152958A (en) 2000-06-09 2002-11-20 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152958A IL152958A (en) 2000-06-09 2002-11-20 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls

Country Status (12)

Country Link
US (1) US6329557B1 (ja)
EP (1) EP1289916B1 (ja)
JP (1) JP4029032B2 (ja)
CN (1) CN1212299C (ja)
AT (1) ATE404516T1 (ja)
AU (1) AU2001266277A1 (ja)
DE (1) DE60135330D1 (ja)
ES (1) ES2311525T3 (ja)
IL (2) IL152958A0 (ja)
MX (1) MXPA02011792A (ja)
NO (1) NO328529B1 (ja)
WO (1) WO2001094279A2 (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2358862B (en) * 1999-12-21 2004-07-21 Fermentron Ltd Processes for Extracting Carotenoids from Biomass Carotenoid Sources
US6784351B2 (en) * 2001-06-29 2004-08-31 Ball Horticultural Company Targetes erecta marigolds with altered carotenoid compositions and ratios
US7575766B2 (en) * 2001-06-29 2009-08-18 Ball Horticultural Company Tagetes erecta with altered carotenoid compositions and ratios
CN1309693C (zh) * 2002-02-05 2007-04-11 海宁凤鸣叶绿素有限公司 一种从万寿菊花制备叶黄素结晶的方法
US7383788B2 (en) * 2002-03-11 2008-06-10 Dsm Ip Assets B.V. Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract
US6737535B2 (en) 2002-06-05 2004-05-18 Kancor Flavours And Extracts Limited Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US6743953B2 (en) 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
US20040176475A1 (en) * 2003-03-07 2004-09-09 Mark Hoffman Isolation of lutein from alfalfa
US7109361B2 (en) * 2003-03-07 2006-09-19 Nu-Tein Co., Inc. Isolation of lutein from alfalfa
US7541166B2 (en) * 2003-09-19 2009-06-02 Microfluidic Systems, Inc. Sonication to selectively lyse different cell types
PE20050398A1 (es) * 2003-09-22 2005-06-03 Rosales Jose Antonio Socla Proceso y purificacion de las xantofilas de marigold
WO2005075575A1 (en) * 2004-02-10 2005-08-18 Nestec S.A. Compositions containing cis-isomers of a carotenoid compound and process
WO2007087815A2 (en) 2004-12-17 2007-08-09 Metanomics Gmbh Process for the control of production of fine chemicals
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
WO2006086707A2 (en) * 2005-02-11 2006-08-17 Kalamazoo Holdings, Inc. Extracts of asteraceae containing reduced levels of phototoxic thiophene derivatives and methods for preparing same
CN1332947C (zh) * 2005-08-03 2007-08-22 浙江医药股份有限公司新昌制药厂 一种从植物油树脂中分离提纯叶黄素晶体的方法
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US7629007B2 (en) * 2005-12-19 2009-12-08 Industrias Vepinsa, S.A. de C.V. Process for purification of free xanthophylls
US7671242B2 (en) * 2005-12-21 2010-03-02 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isolation of aflatoxin-free lutein from aflatoxin-contaminated plants and plant products
ES2281277B1 (es) * 2005-12-29 2008-06-16 Investigaciones Quimicas Y Farmaceuticas, S.A. Procedimiento para la preparacion de xantofilas de origen natural de elevada pureza.
ES2281276B1 (es) * 2005-12-29 2008-06-16 Investigaciones Quimicas Y Farmaceuticas, S.A. Procedimiento para la preparacion de concentrados de xantofilas.
US7943804B2 (en) * 2006-02-21 2011-05-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Lutein extraction from ozone-treated plant sources
AT503329A1 (de) * 2006-03-02 2007-09-15 Omnica Gmbh Verfahren zur herstellung einer zusammensetzung, welche zumindest ein xantophyll enthält
US20080124755A1 (en) * 2006-10-12 2008-05-29 Michael Tai-Man Louie Biosynthesis of beta-cryptoxanthin in microbial hosts using an Arabidopsis thaliana beta-carotene hydroxylase gene
EP2196207B1 (en) 2008-12-12 2012-09-05 Allied Biotech Corporation Method for the purification of carotenoids from plant extracts and the products so obtained
WO2010138210A1 (en) 2009-05-29 2010-12-02 Kalamazoo Holdings, Inc. Methods of saponifying xanthophyll esters and isolating xanthophylls
US8247615B2 (en) 2010-05-14 2012-08-21 Kalamazoo Holdings, Inc. Process of converting esterified xanthophylls from Capsicum to non-esterified xanthophylls in high yields and purities
WO2011145112A1 (en) 2010-05-17 2011-11-24 Dynadis Biotehc (India) Private Limited Process for isolation and purification of carotenoids
CN104919050A (zh) 2012-09-12 2015-09-16 布特马斯先进生物燃料有限责任公司 用于生产发酵产物的工艺和系统
RU2649618C2 (ru) 2012-12-19 2018-04-04 Новас Интернэшнл Инк. Ксантофильные композиции и способы их применения
ES2680471T3 (es) * 2014-03-28 2018-09-07 Dsm Ip Assets B.V. Procedimiento para aislar un carotenoide a partir de un bioorganismo productor de carotenoides
CN109463491A (zh) * 2019-01-07 2019-03-15 刘安军 一种富含水溶性叶绿素的速溶绿茶及其制备方法
KR102523297B1 (ko) * 2020-12-23 2023-04-20 박수민 메리골드를 이용한 설포라판 함유 기능성 유정란 생산용 사료 조성물 및 이를 이용한 유정란 생산 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048203A (en) 1976-12-06 1977-09-13 Thomas Philip Purification of lutein-fatty acid esters from plant materials
US5382714A (en) 1994-03-17 1995-01-17 The Catholic University Of America Process for isolation, purification, and recrystallization of lutein from saponified marigold oleoresin and uses thereof
US5523494A (en) 1994-07-20 1996-06-04 Industrial Organica, S.A. De C.V. Process for the isomerization of lutein
JP3398248B2 (ja) 1995-03-16 2003-04-21 新日本石油株式会社 キサントフィル化合物の精製方法
US5648564A (en) 1995-12-21 1997-07-15 Kemin Industries, Inc. Process for the formation, isolation and purification of comestible xanthophyll crystals from plants
US5973211A (en) 1997-07-18 1999-10-26 Prodemex, S.A. De C.V. Pigmenting efficiency of a natural xanthophyll by isomerization
WO1999020587A1 (en) 1997-10-21 1999-04-29 Office Of Technology Liaison Process for extraction and purification of lutein, zeaxanthin and rare carotenoids from marigold flowers and plants
US6191293B1 (en) * 1998-04-20 2001-02-20 Inexa, Industria Extractora C.A. Trans-xanthophyll ester concentrates of enhanced purity and methods of making same

Also Published As

Publication number Publication date
JP4029032B2 (ja) 2008-01-09
AU2001266277A1 (en) 2001-12-17
ES2311525T3 (es) 2009-02-16
WO2001094279A2 (en) 2001-12-13
JP2003535835A (ja) 2003-12-02
EP1289916A4 (en) 2005-06-15
EP1289916B1 (en) 2008-08-13
IL152958A (en) 2007-08-19
US6329557B1 (en) 2001-12-11
NO20025785D0 (no) 2002-12-02
NO20025785L (no) 2002-12-02
CN1434792A (zh) 2003-08-06
MXPA02011792A (es) 2004-05-14
DE60135330D1 (de) 2008-09-25
EP1289916A2 (en) 2003-03-12
WO2001094279A3 (en) 2002-04-11
CN1212299C (zh) 2005-07-27
NO328529B1 (no) 2010-03-15
ATE404516T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
IL152958A0 (en) Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
WO2001098236A3 (en) 7-phenyl-substituted tetracycline compounds
AU2003243238A1 (en) PROCESS FOR THE OLIGOMERIZATION OF Alpha-OLEFINS HAVING LOW UNSATURATION
PT1671949E (pt) Piridinilaminas substituídas
WO2002099034A3 (en) Sequences for detection and identification of methicillin-resistant staphyloccocus aureus
ATE271382T1 (de) Pulverformulierungen, die melezitose als verdünnungsmittel enthalten
AU5736494A (en) Cyclic sulfone containing retroviral protease inhibitors
WO2003000922A3 (en) Chimeric immunomodulatory compounds and methods of using the same
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
IL160915A0 (en) Indolizines inhibiting kinase proteins
AU2002323010A1 (en) Process of removing oxygenated contaminants from an olefin composition
HUP0303960A3 (en) Process for the polymerization of olefins
EP1545453A4 (en) METHODS AND REAGENTS FOR THE TREATMENT OF DIFFICULT CLOSTRIDIUM INFECTIONS AND DISEASES ASSOCIATED WITH THE SAME
HUP0402396A2 (hu) Aszkomicintartalmú, a szem kezelésére szolgáló készítmények
GB0011358D0 (en) Novel use
PL369175A1 (en) Processes for the purification of higher diamondoids and compositions comprising such diamondoids
AU2002237265A1 (en) Ring-shaped seal
ITGE930109A0 (it) Riduttore di pressione per primo stadio di autorespiratori bistadio.
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
AU148078S (en) Bottle
WO2002102324A3 (en) Anti-arthropod vector vaccines methods of selecting and uses thereof
AU2002352251A1 (en) Expression vector for the production of annexin v
PL374103A1 (en) Use of one or more shogaol(s) as an aphrodisiac
PT1412314E (pt) Repelente de insectos
ES2131467A1 (es) Utilizacion de acido maslinico como inhibidor de serin-proteasas para el tratamiento de enfermedades causadas por parasitos del genero cryptosporidium.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed